e6vk
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
July 25, 2007
QIMONDA AG
Gustav-Heinemann-Ring 212
D-81739 Munich
Federal Republic of Germany
Tel: +49-89-60088-0
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
     
Form 20-F þ   Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
     
Yes o   No þ
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-___.
 
 

 


TABLE OF CONTENTS

SIGNATURES


Table of Contents

This Report on Form 6-K contains the press release for the third financial quarter ended June 30, 2007 of Qimonda AG dated July 25, 2007.

 


Table of Contents

(QUIMONDA LOGO)
News Release Presseinformation
Page 1 of 7 July 24, 2006
Qimonda Reports Third Quarter Results of Financial Year 2007
Munich, Germany — July 24, 2007 — Qimonda AG (NYSE: QI) today announced results for the third quarter of its financial year (FY) 2007, which ended June 30, 2007. Qimonda achieved net sales of Euro 740 million in the third quarter of FY 2007, a decline of 24 percent from Euro 977 million year over year and a decline of 25 percent from Euro 984 million quarter over quarter. Third quarter FY 2007 EBIT was a loss of Euro 323 million compared to positive EBIT of Euro 100 million in the third quarter of FY 2006 and positive EBIT of Euro 85 million in the second quarter of FY 2007. Net loss in the third quarter was Euro 218 million or a loss per share (basic and diluted) of Euro 0.64 compared to net income of Euro 54 million in the third quarter of FY 2006 or earnings per share of Euro 0.18. In the second quarter, net income was Euro 57 million and earnings per share was Euro 0.17.
For the first nine months of FY 2007, Qimonda’s net sales were Euro 2.9 billion, an increase of 12 percent compared to the same period last year. EBIT for the first nine months of the current financial year was Euro 12 million compared to an EBIT loss of Euro 2 million in the same period of the previous financial year. Net income in the first nine months of FY 2007 amounted to Euro 16 million or earnings per share of Euro 0.05 compared to a net loss of Euro 82 million or loss per share of Euro 0.27 in the first nine months of FY 2006.
“In the June quarter, the industry saw a sharp price decline for standard DRAM products, where PC contract prices dropped almost 60 percent quarter over quarter,” said Kin Wah Loh, President and CEO of Qimonda. “Our diversified DRAM product

 


Table of Contents

Page 2 of 7 July 24, 2006
portfolio helped limit our average selling price decline to 40 percent quarter over quarter. Although we have seen some price improvement in July, as we enter the typically stronger second half of the calendar year, we are taking several actions to improve our financial performance. For the current financial year, we are limiting our capital spending and expect to be around Euro 900 million, at the low end of our previously announced range. For the next financial year, we are significantly cutting capital spending plans down to a range of Euro 650 million to Euro 750 million. We are focusing on productivity improvements and expect to convert more than 50 percent of our capacities to 80nm and 75nm by the end of calendar year 2007 while growing our 300mm share to 80 percent. In addition, we are curtailing our operating expenses for the current financial year and expect to save about Euro 30 million compared to our previous plans.”
On a year-over-year basis, Qimonda’s quarterly net sales decreased mainly due to a strong decline in average selling prices as well as a weaker US dollar. These effects were not entirely offset by the 56 percent growth in bit-shipments. Quarter over quarter, net sales decreased mainly due to a 40 percent decline in average selling prices and a weaker U.S. dollar. This decrease, however, was only partially offset by the strong 28 percent growth in bit-shipments and a fairly stable shipment share to non-PC applications of almost 50 percent.
In the third quarter of FY 2007, Qimonda generated 33 percent of its net sales in North America, 16 percent in Europe, 31 percent in Asia Pacific and 20 percent in Japan.

 


Table of Contents

Page 3 of 7 July 24, 2006
Gross margin and net income year over year and quarter over quarter were negatively affected by the DRAM price development and a weaker U.S. dollar. These effects could not be offset by higher bit-shipments and improved manufacturing productivity. The sharp decline in prices for standard DRAM products resulted in inventory write-downs of Euro 66 million in the quarter, which further negatively impacted gross margin and profitability.
Cash flow from operations declined to Euro 45 million in the third quarter FY 2007. Capital expenditures were Euro 236 million, mainly for the further expansion of the Richmond 300mm wafer manufacturing facility and equipment upgrades for the further conversion towards the 75nm and smaller DRAM technologies. In addition, the company fully repaid the remaining Euro 48 million balance of the Infineon shareholder loan. At the end of the third quarter of FY 2007, the company’s gross cash position was Euro 892 million and its net cash position was Euro 743 million.
Outlook
In the fourth quarter of FY 2007, Qimonda expects its bit production to grow by 15 to 20 percent, mainly based on increased in-house and partner capacities and continued productivity improvements from the ongoing conversion to 80nm and 75nm technologies. The company targets a share of bit-shipments to non-PC applications of around 50 percent for the fourth quarter, and expects the trend of strong demand for PC-related products in particular to continue.
For the full financial year, Qimonda expects bit demand for DRAM to be driven by the continued strong growth in graphics, consumer and communication applications and the move to higher density modules in the PC market. For financial year 2007, the company

 


Table of Contents

Page 4 of 7 July 24, 2006
continues to estimate an increase in its bit production of between 60 and 70 percent. Qimonda continues to expect its share of bit-shipments to non-PC applications to be more than 50 percent for the full financial year.
Unaudited Financial Information
Attached is Qimonda’s unaudited financial information for the third quarter and first nine months of its 2007 financial year, which ended June 30, 2007. This financial information includes reconciliations of the non-US GAAP financial measures EBIT and net cash position to net income and gross cash position, respectively, which are the closest measures prepared in accordance with US GAAP. Financial information as of dates before and for periods beginning before May 1, 2006 is derived from Qimonda’s combined financial statements prepared in accordance with its carve-out from Infineon, effective on that date.
Conference Call
The company will host a conference call today at 4:30pm EST, 1:30pm PST, 9:30pm GMT, and 10:30pm CET to discuss its financial results. The web cast and slide presentation will be available at www.qimonda.com. A webcast replay will be available for a limited time on the company’s web site. An audio replay of the conference call will also be available at phone number +1 718 354 1112 (US), +44 (0)20 7806 1970 (UK), +49 (0)69 22222 0418 (Germany), +81 (0)3 3570 8212 (Japan), pass code: 2394883 #, beginning at 6:30pm EST today and continuing until 5:59pm EST on July 28, 2007.
About Qimonda
Qimonda AG (NYSE: QI) is a leading global memory supplier with a broad diversified DRAM product portfolio. The company generated net sales of 3.81 billion in its 2006

 


Table of Contents

Page 5 of 7 July 24, 2006
financial year and has approximately 13,000 employees worldwide. Qimonda has access to five 300mm manufacturing sites on three continents and operates five major R&D facilities. The company provides DRAM products for a wide variety of applications, including in the computing, infrastructure, graphics, mobile and consumer areas, using its power saving technologies and designs. Further information is available at www.qimonda.com.
Disclaimer
This presentation contains forward-looking statements based on assumptions and forecasts made by Qimonda management and third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates and projections, and speak only as of the date they are made. We undertake no obligation to update any of them in light of new information or future events. These forward-looking statements involve inherent risks and are subject to a number of uncertainties, including trends in demand and prices for semiconductors generally and for our products in particular, the success of our development efforts, both alone and with our partners, the success of our efforts to introduce new production processes at our facilities and the actions of our competitors, the availability of funds for planned expansion efforts and the outcome of antitrust investigations and litigation matters, as well as other factors. We caution you that these and a number of other known and unknown risks, uncertainties and other factors could cause actual future results, or outcomes to differ materially from those expressed in any forward-looking statement. These factors include those identified under the heading “Risk Factors” in our Annual Report on Form 20-F for our fiscal year ended September 30, 2006, available without charge on our website and at www.sec.gov.

 


Table of Contents

Page 6 of 7 July 24, 2006
Qimonda AG and Subsidiaries
Unaudited Financial Information
Third Quarter Ended 30.06.2007
All amounts in Euro millions, except where otherwise stated
                                         
 
    3 Months     3 Months     3 Months     9 Months     9 Months  
    June 30     March 31     June 30     June 30     June 30  
    Q3 F07     Q2 F07     Q3 F06     FY 2007     FY 2006  
 
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
RESULTS OF OPERATIONS
                                       
Total net sales
    740       984       977       2.897       2.583  
Cost of goods sold
    (964 )     (785 )     (762 )     (2.572 )     (2.158 )
 
                           
Gross (loss) profit
    (224 )     199       215       325       425  
Research and development expense
    (98 )     (96 )     (110 )     (291 )     (325 )
Selling, general and administrative expense
    (48 )     (48 )     (48 )     (140 )     (161 )
Other operating income (expense), net
    4       3       1       7       (13 )
 
                           
Operating (loss) income
    (366 )     58       58       (99 )     (74 )
Interest income (expense), net
    1       2       (6 )     4       (22 )
Equity in earnings of associated companies
    38       28       11       103       38  
Gain on associated company share issuance
                30             30  
Other non-operating income (expense), net
    6       1       3       12       9  
Minority interests
    (1 )     (2 )     (2 )     (4 )     (5 )
 
                           
Income (loss) before income taxes
    (322 )     87       94       16       (24 )
Income tax benefit (expense)
    104       (30 )     (40 )           (58 )
 
                           
Net (loss) income
    (218 )     57       54       16       (82 )
 
                           
 
                                       
Earnings (loss) per share — basic and diluted (in euro)
    (0,64 )     0,17       0,18       0,05       (0,27 )
 
                                       
FINANCIAL POSITION
                                       
Assets:
                                       
Current assets:
                                       
Cash and cash equivalents
    629       872       438       629       438  
Marketable securities
    263       263       170       263       170  
Trade accounts receivable, net
    364       505       599       364       599  
Inventories
    600       753       672       600       672  
Deferred income taxes
    27       51       50       27       50  
Other current assets
    302       201       234       302       234  
 
                           
Total current assets
    2.185       2.645       2.163       2.185       2.163  
 
                           
 
                                       
Property, plant and equipment, net
    2.129       2.061       2.177       2.129       2.177  
Long-term investments, net
    681       668       601       681       601  
Deferred income taxes
    200       162       139       200       139  
Other assets
    169       172       182       169       182  
 
                           
Total assets
    5.364       5.708       5.262       5.364       5.262  
 
                           
 
                                       
Liabilities and shareholders’/business equity:
                                       
Current liabilities:
                                       
Short-term debt and current maturities
    21       69       451       21       451  
Trade accounts payable
    679       658       608       679       608  
Accrued liabilities
    146       150       137       146       137  
Deferred income taxes
    18       17       16       18       16  
Other current liabilities
    242       294       218       242       218  
 
                           
Total current liabilities
    1.106       1.188       1.430       1.106       1.430  
 
                           
 
                                       
Long-term debt
    128       129       151       128       151  
Deferred income taxes
    34       51       32       34       32  
Other liabilities
    288       292       308       288       308  
 
                           
Total liabilities
    1.556       1.660       1.921       1.556       1.921  
 
                           
Total shareholders’/business equity
    3.808       4.048       3.341       3.808       3.341  
 
                           
Total liabilities and shareholders’/business equity
    5.364       5.708       5.262       5.364       5.262  
 
                           

 


Table of Contents

Page 7 of 7 July 24, 2006
Qimonda AG and Subsidiaries
Unaudited Financial Information
Third Quarter Ended 30.06.2007
All amounts in Euro millions, except where otherwise stated
                                         
 
    3 Months     3 Months     3 Months     9 Months     9 Months  
    June 30     March 31     June 30     June 30     June 30  
    Q3 F07     Q2 F07     Q3 F06     FY 2007     FY 2006  
 
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
CASH FLOW
                                       
 
                                       
Net cash provided by operating activities therein:
    45       286       66       769       61  
Depreciation and amortization
    164       171       177       496       524  
 
                                       
Net cash used in investing activities therein:
    (238 )     (278 )     (257 )     (724 )     (725 )
Net (purchases) proceeds of marketable securities
    (1 )     (119 )     (168 )     (131 )     (168 )
Purchases of property, plant and equipment
    (236 )     (144 )     (89 )     (601 )     (571 )
 
                                       
Net cash (used in) provided by financing activities therein:
    (48 )     (191 )     (14 )     (343 )     466  
Net change in short-term debt due Infineon
    (48 )     (184 )     (19 )     (344 )     (54 )
 
                                       
RECONCILIATIONS
                                       
 
                                       
Net (loss) income
    (218 )     57       54       16       (82 )
Interest income (expense), net
    1       2       (6 )     4       (22 )
 
                           
Earnings (loss) before Interest (EBI)
    (219 )     55       60       12       (60 )
Income tax benefit (expense)
    104       (30 )     (40 )           (58 )
 
                           
Earnings (loss) before Interest and Taxes (EBIT)
    (323 )     85       100       12       (2 )
 
                           
 
                                       
Cash and cash equivalents
    629       872       438       629       438  
Marketable securities
    263       263       170       263       170  
 
                           
Gross Cash position
    892       1.135       608       892       608  
 
                           
 
                                       
Short-term debt and current maturities
    21       69       451       21       451  
Long-term debt
    128       129       151       128       151  
 
                           
Total financial debt
    149       198       602       149       602  
 
                           
 
                                       
Net Cash (debt) position
    743       937       6       743       6  
 
                           
Total shareholders’ equity
    3.808       4.048       3.341       3.808       3.341  
 
                           
Capital Employed
    3.065       3.111       3.335       3.065       3.335  
 
                           
 
                                       
Net cash provided by operating activities
    45       286       66       769       61  
Net cash used in investing activities
    (238 )     (278 )     (257 )     (724 )     (725 )
Net purchases (proceeds) of marketable securities
    1       119       168       131       168  
 
                           
Free Cash Flow
    (192 )     127       (23 )     176       (496 )
 
                           
 
                                       
STATISTICS AND RATIOS
                                       
 
                                       
Gross Margin
    (30 )%     20 %     22 %     11 %     16 %
R&D as % of sales
    13 %     10 %     11 %     10 %     13 %
SG&A as % of sales
    6 %     5 %     5 %     5 %     6 %
EBI / Sales
    (30 )%     6 %     6 %     0 %     (2 )%
EBIT Margin
    (44 )%     9 %     10 %     0 %     (0 )%
Net income / Sales
    (29 )%     6 %     6 %     1 %     (3 )%
Effective Tax Rate
    32 %     34 %     43 %     %     (242 )%
Weighted Average Shares Outstanding (million) — basic
    342       342       300       342       300  
Sales / Equity
    0,8       1,0       1,2       3,0       3,1  
Capital Turnover (Sales / Capital Employed)
    1,0       1,3       1,2       3,8       3,1  
Net income / Equity ratio
    (23 )%     6 %     6 %     1 %     (3 )%
ROCE (EBI / Capital Employed)
    (29 )%     7 %     7 %     1 %     (2 )%
For the Business and Trade Press: QI200707.26e
             
Public Relations
  Name   Phone   E-mail
Worldwide Headquarters
  Ralph Heinrich   +49 89 60088 1300   ralph.heinrich@qimonda.com
U.S.A.
  Donna Wilson   +1 408 501 7188   donna.wilson@qimonda.com
Asia
  Regine Liu   +886 2 2652 6900   regine.liu@qimonda.com
Japan
  Kenichi Sugiyama   +81 3 5745 7339   kenichi.sugiyama@qimonda.com
Investor Relations Worldwide
  Steve Harrison   +1 919 677 6904   steve.harrison@qimonda.com
Investor Relations Europe & Asia
  Andreas Schaller   +49 89 60088 1200   andreas.schaller@qimonda.com

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this press release to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  QIMONDA AG
 
 
Date: July 25, 2007  By:   /s/ Kin Wah Loh    
    Kin Wah Loh   
    Chief Executive Officer and Chairman of the Management Board   
 
     
  By:   /s/ Dr. Michael Majerus    
    Dr. Michael Majerus   
    Chief Financial Officer and Member of the Management Board